{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"acanthosis-nigricans-insulin-resistance-muscle-cramps-acral-enlargement-syndrome","columns":[{"gene":"","key":"MONDO:0008696/ORPHA:90301","label":"Acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome","mondoId":"MONDO:0008696","onsetQualifier":null,"recordKeys":["20fdf7422edcb6c0b6529e078973c8b020ecb6245999b34a9b4c1f55f5ba6692","349ce9d64b4319bf59fc88f3d8bde9b9fcaf44c0d1109aeecc2722e70b543ce7","3580a81f02b3868684b852abf5ea8609525d0eef77577322b27a5665b9c330c5","457924fb33b3f896b178f905c00a39f42b7beeb2eb39aba56dd1817ba0730710","54dccfb219a6691b040014813aeec73112b82e9913402759c6788404e46b732e","83a0acd55c763b51d9b6001d15059cf687a9e977b007c77a4d3ce2c799de450e","b07ff2e12e2d55364780d3c712b9a4d6a8f34b0c0046dffbbf4c506b66cb470b","bafad5730e1f0a7c95e6013b7ad663d23d980346007358379a45380a65556727","ebd5835020b2b58931f76ae5d6890579fb9a6820128427a4978b803b708cea85"],"recordQualifiers":{},"scopeLabel":"ORPHA:90301","sourceIds":["ORPHA:90301"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0008696/ORPHA:90301"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":9,"sourceGroups":{"omim":0,"orphanet":9,"published":0}},"features":[{"hpoId":"HP:0000956","label":"Acanthosis nigricans","primary":false},{"hpoId":"HP:0000845","label":"Elevated circulating growth hormone concentration","primary":false},{"hpoId":"HP:0000105","label":"Enlarged kidney","primary":false},{"hpoId":"HP:0008675","label":"Enlarged polycystic ovaries","primary":false},{"hpoId":"HP:0001007","label":"Hirsutism","primary":false},{"hpoId":"HP:0000855","label":"Insulin resistance","primary":false},{"hpoId":"HP:0000831","label":"Insulin-resistant diabetes mellitus","primary":false},{"hpoId":"HP:0003394","label":"Muscle spasm","primary":false},{"hpoId":"HP:0000147","label":"Polycystic ovaries","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0008696","records":[{"frequencyKind":"range","key":"20fdf7422edcb6c0b6529e078973c8b020ecb6245999b34a9b4c1f55f5ba6692","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:90301","disease_name":"Acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000956","is_excluded":false,"label":"Acanthosis nigricans","onset_id":null,"reference":"ORPHA:90301","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"349ce9d64b4319bf59fc88f3d8bde9b9fcaf44c0d1109aeecc2722e70b543ce7","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:90301","disease_name":"Acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000855","is_excluded":false,"label":"Insulin resistance","onset_id":null,"reference":"ORPHA:90301","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3580a81f02b3868684b852abf5ea8609525d0eef77577322b27a5665b9c330c5","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:90301","disease_name":"Acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001007","is_excluded":false,"label":"Hirsutism","onset_id":null,"reference":"ORPHA:90301","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"457924fb33b3f896b178f905c00a39f42b7beeb2eb39aba56dd1817ba0730710","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:90301","disease_name":"Acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000147","is_excluded":false,"label":"Polycystic ovaries","onset_id":null,"reference":"ORPHA:90301","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"54dccfb219a6691b040014813aeec73112b82e9913402759c6788404e46b732e","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:90301","disease_name":"Acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000845","is_excluded":false,"label":"Elevated circulating growth hormone concentration","onset_id":null,"reference":"ORPHA:90301","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"83a0acd55c763b51d9b6001d15059cf687a9e977b007c77a4d3ce2c799de450e","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:90301","disease_name":"Acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000831","is_excluded":false,"label":"Insulin-resistant diabetes mellitus","onset_id":null,"reference":"ORPHA:90301","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b07ff2e12e2d55364780d3c712b9a4d6a8f34b0c0046dffbbf4c506b66cb470b","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:90301","disease_name":"Acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003394","is_excluded":false,"label":"Muscle spasm","onset_id":null,"reference":"ORPHA:90301","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bafad5730e1f0a7c95e6013b7ad663d23d980346007358379a45380a65556727","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:90301","disease_name":"Acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008675","is_excluded":false,"label":"Enlarged polycystic ovaries","onset_id":null,"reference":"ORPHA:90301","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ebd5835020b2b58931f76ae5d6890579fb9a6820128427a4978b803b708cea85","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:90301","disease_name":"Acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000105","is_excluded":false,"label":"Enlarged kidney","onset_id":null,"reference":"ORPHA:90301","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"acanthosis-nigricans-insulin-resistance-muscle-cramps-acral-enlargement","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome"},"schemaVersion":1}